世界のエプレレノン市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global Eplerenone Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO19295)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO19295
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:90
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のエプレレノン市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

エプレレノン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のエプレレノンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

エプレレノン市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・25mg、50mg

用途別セグメントは次のように区分されます。
・心不全、高血圧

世界のエプレレノン市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Glenmark、APOTEX、Sandoz、Mylan、Accord Healthcare、Unichem、RPG Life Sciences、HBS Healthcare

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、エプレレノン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエプレレノンメーカーの企業概要、2019年~2022年までのエプレレノンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエプレレノンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別エプレレノンの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのエプレレノンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのエプレレノン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびエプレレノンの産業チェーンを掲載しています。
・第13、14、15章では、エプレレノンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- エプレレノンの概要
- 種類別分析(2017年vs2021年vs2028年):25mg、50mg
- 用途別分析(2017年vs2021年vs2028年):心不全、高血圧
- 世界のエプレレノン市場規模・予測
- 世界のエプレレノン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Pfizer、Glenmark、APOTEX、Sandoz、Mylan、Accord Healthcare、Unichem、RPG Life Sciences、HBS Healthcare
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:25mg、50mg
・用途別分析2017年-2028年:心不全、高血圧
・エプレレノンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・エプレレノンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・エプレレノンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エプレレノンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・エプレレノンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Eplerenone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Eplerenone market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Heart failure accounting for % of the Eplerenone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 25 mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Eplerenone include Pfizer, Glenmark, APOTEX, Sandoz, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Eplerenone market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
25 mg
50 mg
Market segment by Application can be divided into
Heart failure
Hypertension
The key market players for global Eplerenone market are listed below:
Pfizer
Glenmark
APOTEX
Sandoz
Mylan
Accord Healthcare
Unichem
RPG Life Sciences
HBS Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eplerenone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eplerenone, with price, sales, revenue and global market share of Eplerenone from 2019 to 2022.
Chapter 3, the Eplerenone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eplerenone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Eplerenone market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Eplerenone.
Chapter 13, 14, and 15, to describe Eplerenone sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Eplerenone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Eplerenone Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 25 mg
1.2.3 50 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Eplerenone Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Heart failure
1.3.3 Hypertension
1.4 Global Eplerenone Market Size & Forecast
1.4.1 Global Eplerenone Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Eplerenone Sales in Volume (2017-2028)
1.4.3 Global Eplerenone Price (2017-2028)
1.5 Global Eplerenone Production Capacity Analysis
1.5.1 Global Eplerenone Total Production Capacity (2017-2028)
1.5.2 Global Eplerenone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Eplerenone Market Drivers
1.6.2 Eplerenone Market Restraints
1.6.3 Eplerenone Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Eplerenone Product and Services
2.1.4 Pfizer Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Glenmark
2.2.1 Glenmark Details
2.2.2 Glenmark Major Business
2.2.3 Glenmark Eplerenone Product and Services
2.2.4 Glenmark Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 APOTEX
2.3.1 APOTEX Details
2.3.2 APOTEX Major Business
2.3.3 APOTEX Eplerenone Product and Services
2.3.4 APOTEX Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Eplerenone Product and Services
2.4.4 Sandoz Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Eplerenone Product and Services
2.5.4 Mylan Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Accord Healthcare
2.6.1 Accord Healthcare Details
2.6.2 Accord Healthcare Major Business
2.6.3 Accord Healthcare Eplerenone Product and Services
2.6.4 Accord Healthcare Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Unichem
2.7.1 Unichem Details
2.7.2 Unichem Major Business
2.7.3 Unichem Eplerenone Product and Services
2.7.4 Unichem Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 RPG Life Sciences
2.8.1 RPG Life Sciences Details
2.8.2 RPG Life Sciences Major Business
2.8.3 RPG Life Sciences Eplerenone Product and Services
2.8.4 RPG Life Sciences Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 HBS Healthcare
2.9.1 HBS Healthcare Details
2.9.2 HBS Healthcare Major Business
2.9.3 HBS Healthcare Eplerenone Product and Services
2.9.4 HBS Healthcare Eplerenone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Eplerenone Breakdown Data by Manufacturer
3.1 Global Eplerenone Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Eplerenone Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Eplerenone
3.4 Market Concentration Rate
3.4.1 Top 3 Eplerenone Manufacturer Market Share in 2021
3.4.2 Top 6 Eplerenone Manufacturer Market Share in 2021
3.5 Global Eplerenone Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Eplerenone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Eplerenone Market Size by Region
4.1.1 Global Eplerenone Sales in Volume by Region (2017-2028)
4.1.2 Global Eplerenone Revenue by Region (2017-2028)
4.2 North America Eplerenone Revenue (2017-2028)
4.3 Europe Eplerenone Revenue (2017-2028)
4.4 Asia-Pacific Eplerenone Revenue (2017-2028)
4.5 South America Eplerenone Revenue (2017-2028)
4.6 Middle East and Africa Eplerenone Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Eplerenone Sales in Volume by Type (2017-2028)
5.2 Global Eplerenone Revenue by Type (2017-2028)
5.3 Global Eplerenone Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Eplerenone Sales in Volume by Application (2017-2028)
6.2 Global Eplerenone Revenue by Application (2017-2028)
6.3 Global Eplerenone Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Eplerenone Sales by Type (2017-2028)
7.2 North America Eplerenone Sales by Application (2017-2028)
7.3 North America Eplerenone Market Size by Country
7.3.1 North America Eplerenone Sales in Volume by Country (2017-2028)
7.3.2 North America Eplerenone Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Eplerenone Sales by Type (2017-2028)
8.2 Europe Eplerenone Sales by Application (2017-2028)
8.3 Europe Eplerenone Market Size by Country
8.3.1 Europe Eplerenone Sales in Volume by Country (2017-2028)
8.3.2 Europe Eplerenone Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Eplerenone Sales by Type (2017-2028)
9.2 Asia-Pacific Eplerenone Sales by Application (2017-2028)
9.3 Asia-Pacific Eplerenone Market Size by Region
9.3.1 Asia-Pacific Eplerenone Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Eplerenone Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Eplerenone Sales by Type (2017-2028)
10.2 South America Eplerenone Sales by Application (2017-2028)
10.3 South America Eplerenone Market Size by Country
10.3.1 South America Eplerenone Sales in Volume by Country (2017-2028)
10.3.2 South America Eplerenone Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Eplerenone Sales by Type (2017-2028)
11.2 Middle East & Africa Eplerenone Sales by Application (2017-2028)
11.3 Middle East & Africa Eplerenone Market Size by Country
11.3.1 Middle East & Africa Eplerenone Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Eplerenone Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Eplerenone and Key Manufacturers
12.2 Manufacturing Costs Percentage of Eplerenone
12.3 Eplerenone Production Process
12.4 Eplerenone Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Eplerenone Typical Distributors
13.3 Eplerenone Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Eplerenone Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Eplerenone Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Eplerenone Product and Services
Table 6. Pfizer Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Glenmark Basic Information, Manufacturing Base and Competitors
Table 8. Glenmark Major Business
Table 9. Glenmark Eplerenone Product and Services
Table 10. Glenmark Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. APOTEX Basic Information, Manufacturing Base and Competitors
Table 12. APOTEX Major Business
Table 13. APOTEX Eplerenone Product and Services
Table 14. APOTEX Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sandoz Basic Information, Manufacturing Base and Competitors
Table 16. Sandoz Major Business
Table 17. Sandoz Eplerenone Product and Services
Table 18. Sandoz Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Eplerenone Product and Services
Table 22. Mylan Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Accord Healthcare Major Business
Table 25. Accord Healthcare Eplerenone Product and Services
Table 26. Accord Healthcare Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Unichem Basic Information, Manufacturing Base and Competitors
Table 28. Unichem Major Business
Table 29. Unichem Eplerenone Product and Services
Table 30. Unichem Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. RPG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 32. RPG Life Sciences Major Business
Table 33. RPG Life Sciences Eplerenone Product and Services
Table 34. RPG Life Sciences Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. HBS Healthcare Basic Information, Manufacturing Base and Competitors
Table 36. HBS Healthcare Major Business
Table 37. HBS Healthcare Eplerenone Product and Services
Table 38. HBS Healthcare Eplerenone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Eplerenone Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Eplerenone Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Eplerenone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Eplerenone Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Eplerenone Production Site of Key Manufacturer
Table 44. Eplerenone New Entrant and Capacity Expansion Plans
Table 45. Eplerenone Mergers & Acquisitions in the Past Five Years
Table 46. Global Eplerenone Sales by Region (2017-2022) & (K Units)
Table 47. Global Eplerenone Sales by Region (2023-2028) & (K Units)
Table 48. Global Eplerenone Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Eplerenone Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Eplerenone Sales by Type (2017-2022) & (K Units)
Table 51. Global Eplerenone Sales by Type (2023-2028) & (K Units)
Table 52. Global Eplerenone Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Eplerenone Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Eplerenone Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Eplerenone Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Eplerenone Sales by Application (2017-2022) & (K Units)
Table 57. Global Eplerenone Sales by Application (2023-2028) & (K Units)
Table 58. Global Eplerenone Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Eplerenone Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Eplerenone Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Eplerenone Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Eplerenone Sales by Country (2017-2022) & (K Units)
Table 63. North America Eplerenone Sales by Country (2023-2028) & (K Units)
Table 64. North America Eplerenone Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Eplerenone Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Eplerenone Sales by Type (2017-2022) & (K Units)
Table 67. North America Eplerenone Sales by Type (2023-2028) & (K Units)
Table 68. North America Eplerenone Sales by Application (2017-2022) & (K Units)
Table 69. North America Eplerenone Sales by Application (2023-2028) & (K Units)
Table 70. Europe Eplerenone Sales by Country (2017-2022) & (K Units)
Table 71. Europe Eplerenone Sales by Country (2023-2028) & (K Units)
Table 72. Europe Eplerenone Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Eplerenone Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Eplerenone Sales by Type (2017-2022) & (K Units)
Table 75. Europe Eplerenone Sales by Type (2023-2028) & (K Units)
Table 76. Europe Eplerenone Sales by Application (2017-2022) & (K Units)
Table 77. Europe Eplerenone Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Eplerenone Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Eplerenone Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Eplerenone Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Eplerenone Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Eplerenone Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Eplerenone Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Eplerenone Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Eplerenone Sales by Application (2023-2028) & (K Units)
Table 86. South America Eplerenone Sales by Country (2017-2022) & (K Units)
Table 87. South America Eplerenone Sales by Country (2023-2028) & (K Units)
Table 88. South America Eplerenone Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Eplerenone Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Eplerenone Sales by Type (2017-2022) & (K Units)
Table 91. South America Eplerenone Sales by Type (2023-2028) & (K Units)
Table 92. South America Eplerenone Sales by Application (2017-2022) & (K Units)
Table 93. South America Eplerenone Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Eplerenone Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Eplerenone Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Eplerenone Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Eplerenone Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Eplerenone Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Eplerenone Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Eplerenone Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Eplerenone Sales by Application (2023-2028) & (K Units)
Table 102. Eplerenone Raw Material
Table 103. Key Manufacturers of Eplerenone Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Eplerenone Typical Distributors
Table 107. Eplerenone Typical Customers
List of Figures
Figure 1. Eplerenone Picture
Figure 2. Global Eplerenone Revenue Market Share by Type in 2021
Figure 3. 25 mg
Figure 4. 50 mg
Figure 5. Global Eplerenone Revenue Market Share by Application in 2021
Figure 6. Heart failure
Figure 7. Hypertension
Figure 8. Global Eplerenone Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Eplerenone Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Eplerenone Sales (2017-2028) & (K Units)
Figure 11. Global Eplerenone Price (2017-2028) & (USD/Unit)
Figure 12. Global Eplerenone Production Capacity (2017-2028) & (K Units)
Figure 13. Global Eplerenone Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Eplerenone Market Drivers
Figure 15. Eplerenone Market Restraints
Figure 16. Eplerenone Market Trends
Figure 17. Global Eplerenone Sales Market Share by Manufacturer in 2021
Figure 18. Global Eplerenone Revenue Market Share by Manufacturer in 2021
Figure 19. Eplerenone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Eplerenone Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Eplerenone Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Eplerenone Sales Market Share by Region (2017-2028)
Figure 23. Global Eplerenone Revenue Market Share by Region (2017-2028)
Figure 24. North America Eplerenone Revenue (2017-2028) & (USD Million)
Figure 25. Europe Eplerenone Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Eplerenone Revenue (2017-2028) & (USD Million)
Figure 27. South America Eplerenone Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Eplerenone Revenue (2017-2028) & (USD Million)
Figure 29. Global Eplerenone Sales Market Share by Type (2017-2028)
Figure 30. Global Eplerenone Revenue Market Share by Type (2017-2028)
Figure 31. Global Eplerenone Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Eplerenone Sales Market Share by Application (2017-2028)
Figure 33. Global Eplerenone Revenue Market Share by Application (2017-2028)
Figure 34. Global Eplerenone Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Eplerenone Sales Market Share by Type (2017-2028)
Figure 36. North America Eplerenone Sales Market Share by Application (2017-2028)
Figure 37. North America Eplerenone Sales Market Share by Country (2017-2028)
Figure 38. North America Eplerenone Revenue Market Share by Country (2017-2028)
Figure 39. United States Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Eplerenone Sales Market Share by Type (2017-2028)
Figure 43. Europe Eplerenone Sales Market Share by Application (2017-2028)
Figure 44. Europe Eplerenone Sales Market Share by Country (2017-2028)
Figure 45. Europe Eplerenone Revenue Market Share by Country (2017-2028)
Figure 46. Germany Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Eplerenone Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Eplerenone Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Eplerenone Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Eplerenone Revenue Market Share by Region (2017-2028)
Figure 55. China Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Eplerenone Sales Market Share by Type (2017-2028)
Figure 62. South America Eplerenone Sales Market Share by Application (2017-2028)
Figure 63. South America Eplerenone Sales Market Share by Country (2017-2028)
Figure 64. South America Eplerenone Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Eplerenone Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Eplerenone Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Eplerenone Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Eplerenone Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Eplerenone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Eplerenone in 2021
Figure 76. Manufacturing Process Analysis of Eplerenone
Figure 77. Eplerenone Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO19295 )"世界のエプレレノン市場2022年:市場規模予測(~2028年)" (英文:Global Eplerenone Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。